Work

A Klotho-Derived Peptide as a Possible Novel Drug to Prevent Kidney Fibrosis

Year: 2022

Type: editorial

Source: American Journal of Kidney Diseases

DOI: 10.1053/j.ajkd.2022.03.006

Authors: Tamara Isakova, Christopher Yanucil, Christian Faul

Institutions: Northwestern University, University of Alabama at Birmingham, UAB Medicine

Language: English

Topic: Chronic Kidney Disease and Diabetes

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: University of Alabama at Birmingham, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Hyperphosphatemia Contributes to Systemic Inflammation and Anemia in Chronic Kidney Disease, Mentored patient-oriented research of novel mechanisms for cardiovascular disease in patients with chronic kidney disease, Activation of Cardiac FGFR4 Causes Left Ventricular Hypertrophy, Changes in phosphate metabolism cause pathologic cardiac remodeling in chronic kidney disease (CKD), Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases, Novel Diagnostics and Therapeutic Targets for Calcification in CKD, Chicago Kidney Urology Hematology network FOR city-Wide reseArch tRaining and career Development (Chicago KUH FORWARD)

OpenAlex ID: W4224216280

Cites: 18

Cited by: 10

Related to: 10